Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Laos
Laos: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 63.0% in 2024. ▼ Falling
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Laos, 2014–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
The most recent figure for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Laos is 63.0%, measured in 2024.
That represents a change of down 6.0% on the previous year and down 7.4% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Laos peaked at 78.0% in 2016 and was at its lowest, 58.0%, in 2020.
Laos ranks 129th of 146 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 11 years of available data.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Laos, year by year
| Year | % | Change |
|---|---|---|
| 2014 | 68.0% | — |
| 2015 | 71.0% | +4.4% |
| 2016 | 78.0% | +9.9% |
| 2017 | 76.0% | -2.6% |
| 2018 | 74.0% | -2.6% |
| 2019 | 62.0% | -16.2% |
| 2020 | 58.0% | -6.5% |
| 2021 | 60.0% | +3.4% |
| 2022 | 64.0% | +6.7% |
| 2023 | 67.0% | +4.7% |
| 2024 | 63.0% | -6.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 71.5% | 62.0% | 78.0% | 6 |
| 2020s | 62.4% | 58.0% | 67.0% | 5 |
Countries ranked near Laos
- 126 Iraq 65.0% compare
- 127 Benin 64.0% compare
- 127 Madagascar 64.0% compare
- 129 Democratic Republic of Congo 63.0% compare
- 131 Angola 62.0% compare
- 131 Marshall Islands 62.0% compare
More health data for Laos
- Un projection of annual infant deaths, annual growth rate -2.76 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5667 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,260 deaths per 1,000 people (2090)
- Number of infants who die before age 1 317 deaths (2100)
- Population ages 0-14, female, annual growth rate 0.0948 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1462 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.1538 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1522 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Laos?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Laos was 63.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Laos?
- The highest recorded value was 78.0% in 2016.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Laos?
- The lowest recorded value was 58.0% in 2020.
- How does Laos rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Laos ranks 129th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Laos?
- Over the last ten years it is down 7.4%. The long-run trend across the full record is falling.
- Where does this Laos data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.